J&J Says A Booster Shot For Its Vaccine May Have Big Benefits

A nurse fills a syringe with Johnson & & Johnsons COVID-19 vaccine at a center in Pasadena, Calif., on Thursday.

Robyn Beck/AFP via Getty Images

toggle caption

hide caption

Robyn Beck/AFP through Getty Images

A nurse fills a syringe with Johnson & & Johnsons COVID-19 vaccine at a center in Pasadena, Calif., on Thursday.

Robyn Beck/AFP via Getty Images

” We have established that a single shot of our COVID-19 vaccine generates strong and robust immune actions that are resilient and consistent through 8 months,” said Mathai Mammen, international head of Janssen Research & & Development, Johnson & & Johnson, in a statement. “With these new information, we likewise see that a booster dosage of the Johnson & & Johnson COVID-19 vaccine further increases antibody reactions amongst research study participants who had actually previously received our vaccine,” he added. The information have actually not yet been published in a scientific journal or reviewed by other researchers.

The Biden administration has currently announced plans to begin rolling out boosters in September for people who received the Moderna and Pfizer vaccines. People 18 years and older who got the Pfizer or Moderna vaccines will be eligible for a booster dosage 8 months after their 2nd dose.

The World Health Organization has called on nations to postpone their strategies for booster shots until countries with lower vaccination rates can vaccinate more of their population. Just over 14 million individuals have received the Johnson & & Johnson vaccine, the tiniest share amongst the 3 vaccines being utilized in the U.S., according to the Centers for Disease Control and Prevention. The Pfizer vaccine has been administered to more than 205 million individuals, and almost 144 million have actually gotten the Moderna shot, the CDC said.

Johnson & & Johnson says it has proof that individuals who got its one-shot COVID-19 vaccine might benefit from a booster shot after 6 months. The pharmaceutical giant stated in a press release Wednesday that when it offered participants in a research study a second jab of its coronavirus vaccine after 6 months, their antibody levels were nine times higher than 28 days after their first dose. If the vaccines efficiency starts to wane, the information recommends that an extra shot might serve as a booster.

Several independent researchers stated the finding would most likely support offering individuals boosters with the Johnson & & Johnson vaccine. “It would be affordable to say that yes, have at least two dosages of J&J, or have at least one more dose for those who had a single dose, consisting of the option of having another J&J,” stated Saad Omer, a vaccine researcher at Yale. “It is pointing toward the utility of a 2nd dosage.

The pharmaceutical giant said in a news release Wednesday that when it provided individuals in a study a second jab of its coronavirus vaccine after 6 months, their antibody levels were 9 times greater than 28 days after their first dosage. “With these new information, we likewise see that a booster dosage of the Johnson & & Johnson COVID-19 vaccine further boosts antibody reactions among research study participants who had actually previously received our vaccine,” he added. People 18 years and older who got the Pfizer or Moderna vaccines will be eligible for a booster dose 8 months after their 2nd dose. Just over 14 million individuals have received the Johnson & & Johnson vaccine, the smallest share amongst the three vaccines being utilized in the U.S., according to the Centers for Disease Control and Prevention. “It would be sensible to say that yes, have at least 2 dosages of J&J, or have at least one more dose for those who had a single dosage, including the alternative of having another J&J,” said Saad Omer, a vaccine scientist at Yale.

Leave a Reply

Your email address will not be published. Required fields are marked *